Click for best price
Tumor Necrosis Factor TNF Inhibitor Drugs Market Size, Share 2022
TNF inhibitors are drugs that help stop inflammation. They're used to treat diseases like rheumatoid arthritis (RA), juvenile arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis, ulcerative colitis (UC), and Crohn's disease.They're also called TNF blockers, biologic therapies, or anti-TNF drugs.
This report contains market size and forecasts of Tumor Necrosis Factor (TNF) Inhibitor Drugs in global, including the following market information:
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Tumor Necrosis Factor (TNF) Inhibitor Drugs companies in 2021 (%)
The global Tumor Necrosis Factor (TNF) Inhibitor Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Remicade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tumor Necrosis Factor (TNF) Inhibitor Drugs include Takeda Pharmaceuticals, Amgen, AbbVie, Pfizer, Novartis, Johnson and Johnson, UCB, Merck and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tumor Necrosis Factor (TNF) Inhibitor Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, by Type, 2021 (%)
Remicade
Humira
Cimzia
Simponi
Others
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, by Application, 2021 (%)
Online Pharmacies
Specialty Pharmacies
Hospital Pharmacies
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs revenues share in global market, 2021 (%)
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Tumor Necrosis Factor (TNF) Inhibitor Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda Pharmaceuticals
Amgen
AbbVie
Pfizer
Novartis
Johnson and Johnson
UCB
Merck
Abbott Laboratories
Biogen
Gilead Sciences
Thermo Fisher Scientific
Bristol-Myers Squibb
Astellas Pharma
AstraZeneca
Eli Lilly and Company
Roche
Sanofi
| Report Attributes |
Report Details |
| Report Title |
Tumor Necrosis Factor (TNF) Inhibitor Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
118 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Overall Market Size
2.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size: 2021 VS 2028
2.2 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players in Global Market
3.2 Top Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies Ranked by Revenue
3.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Companies
3.4 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Companies
3.5 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Players in Global Market
3.8.1 List of Global Tier 1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size Markets, 2021 & 2028
4.1.2 Remicade
4.1.3 Humira
4.1.4 Cimzia
4.1.5 Simponi
4.1.6 Others
4.2 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
4.2.1 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2022
4.2.2 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2023-2028
4.2.3 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales & Forecasts
4.3.1 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2017-2022
4.3.2 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2023-2028
4.3.3 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2021 & 2028
5.1.2 Online Pharmacies
5.1.3 Specialty Pharmacies
5.1.4 Hospital Pharmacies
5.2 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
5.2.1 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2022
5.2.2 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2023-2028
5.2.3 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales & Forecasts
5.3.1 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2017-2022
5.3.2 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2023-2028
5.3.3 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2021 & 2028
6.2 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue & Forecasts
6.2.1 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2022
6.2.2 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2023-2028
6.2.3 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales & Forecasts
6.3.1 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2017-2022
6.3.2 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2023-2028
6.3.3 By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.4.2 By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2017-2028
6.4.3 US Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4.4 Canada Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.4.5 Mexico Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2017-2028
6.5.3 Germany Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.4 France Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.5 U.K. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.6 Italy Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.7 Russia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.5.9 Benelux Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2017-2028
6.6.3 China Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.6.4 Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.6.5 South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.6.7 India Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.7.2 By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2017-2028
6.7.3 Brazil Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.7.4 Argentina Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, 2017-2028
6.8.3 Turkey Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.8.4 Israel Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
6.8.6 UAE Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Takeda Pharmaceuticals
7.1.1 Takeda Pharmaceuticals Corporate Summary
7.1.2 Takeda Pharmaceuticals Business Overview
7.1.3 Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.1.4 Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Takeda Pharmaceuticals Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.2.4 Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.3.4 AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.3.5 AbbVie Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.4.4 Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.5.4 Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Novartis Key News
7.6 Johnson and Johnson
7.6.1 Johnson and Johnson Corporate Summary
7.6.2 Johnson and Johnson Business Overview
7.6.3 Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.6.4 Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Johnson and Johnson Key News
7.7 UCB
7.7.1 UCB Corporate Summary
7.7.2 UCB Business Overview
7.7.3 UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.7.4 UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.7.5 UCB Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.8.4 Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporate Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.9.4 Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Abbott Laboratories Key News
7.10 Biogen
7.10.1 Biogen Corporate Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.10.4 Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Biogen Key News
7.11 Gilead Sciences
7.11.1 Gilead Sciences Corporate Summary
7.11.2 Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Overview
7.11.3 Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.11.4 Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Gilead Sciences Key News
7.12 Thermo Fisher Scientific
7.12.1 Thermo Fisher Scientific Corporate Summary
7.12.2 Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Overview
7.12.3 Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.12.4 Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Thermo Fisher Scientific Key News
7.13 Bristol-Myers Squibb
7.13.1 Bristol-Myers Squibb Corporate Summary
7.13.2 Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Business Overview
7.13.3 Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.13.4 Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Bristol-Myers Squibb Key News
7.14 Astellas Pharma
7.14.1 Astellas Pharma Corporate Summary
7.14.2 Astellas Pharma Business Overview
7.14.3 Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.14.4 Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Astellas Pharma Key News
7.15 AstraZeneca
7.15.1 AstraZeneca Corporate Summary
7.15.2 AstraZeneca Business Overview
7.15.3 AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.15.4 AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.15.5 AstraZeneca Key News
7.16 Eli Lilly and Company
7.16.1 Eli Lilly and Company Corporate Summary
7.16.2 Eli Lilly and Company Business Overview
7.16.3 Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.16.4 Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Eli Lilly and Company Key News
7.17 Roche
7.17.1 Roche Corporate Summary
7.17.2 Roche Business Overview
7.17.3 Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.17.4 Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Roche Key News
7.18 Sanofi
7.18.1 Sanofi Corporate Summary
7.18.2 Sanofi Business Overview
7.18.3 Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Major Product Offerings
7.18.4 Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Sanofi Key News
8 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity, Analysis
8.1 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity, 2017-2028
8.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tumor Necrosis Factor (TNF) Inhibitor Drugs Supply Chain Analysis
10.1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry Value Chain
10.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Upstream Market
10.3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tumor Necrosis Factor (TNF) Inhibitor Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Tumor Necrosis Factor (TNF) Inhibitor Drugs in Global Market
Table 2. Top Tumor Necrosis Factor (TNF) Inhibitor Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales by Companies, (MT), 2017-2022
Table 6. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Tumor Necrosis Factor (TNF) Inhibitor Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Type
Table 9. List of Global Tier 1 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Necrosis Factor (TNF) Inhibitor Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), 2017-2022
Table 15. By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), 2023-2028
Table 16. By Application ? Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), 2017-2022
Table 20. By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), 2023-2028
Table 21. By Region ? Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), 2017-2022
Table 25. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), 2023-2028
Table 26. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2017-2022
Table 29. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2023-2028
Table 30. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2017-2022
Table 33. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2023-2028
Table 34. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2017-2022
Table 37. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2023-2028
Table 38. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2017-2022
Table 41. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2023-2028
Table 42. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2017-2022
Table 45. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales, (MT), 2023-2028
Table 46. Takeda Pharmaceuticals Corporate Summary
Table 47. Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 48. Takeda Pharmaceuticals Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 51. Amgen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. AbbVie Corporate Summary
Table 53. AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 54. AbbVie Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 57. Pfizer Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Novartis Corporate Summary
Table 59. Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 60. Novartis Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Johnson and Johnson Corporate Summary
Table 62. Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 63. Johnson and Johnson Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. UCB Corporate Summary
Table 65. UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 66. UCB Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 69. Merck Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Abbott Laboratories Corporate Summary
Table 71. Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 72. Abbott Laboratories Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Biogen Corporate Summary
Table 74. Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 75. Biogen Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Gilead Sciences Corporate Summary
Table 77. Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 78. Gilead Sciences Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. Thermo Fisher Scientific Corporate Summary
Table 80. Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 81. Thermo Fisher Scientific Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 82. Bristol-Myers Squibb Corporate Summary
Table 83. Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 84. Bristol-Myers Squibb Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 85. Astellas Pharma Corporate Summary
Table 86. Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 87. Astellas Pharma Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 88. AstraZeneca Corporate Summary
Table 89. AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 90. AstraZeneca Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 91. Eli Lilly and Company Corporate Summary
Table 92. Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 93. Eli Lilly and Company Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 94. Roche Corporate Summary
Table 95. Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 96. Roche Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 97. Sanofi Corporate Summary
Table 98. Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Product Offerings
Table 99. Sanofi Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales (MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 100. Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity (MT) of Key Manufacturers in Global Market, 2020-2022 (MT)
Table 101. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 102. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production by Region, 2017-2022 (MT)
Table 103. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production by Region, 2023-2028 (MT)
Table 104. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Opportunities & Trends in Global Market
Table 105. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Drivers in Global Market
Table 106. Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Restraints in Global Market
Table 107. Tumor Necrosis Factor (TNF) Inhibitor Drugs Raw Materials
Table 108. Tumor Necrosis Factor (TNF) Inhibitor Drugs Raw Materials Suppliers in Global Market
Table 109. Typical Tumor Necrosis Factor (TNF) Inhibitor Drugs Downstream
Table 110. Tumor Necrosis Factor (TNF) Inhibitor Drugs Downstream Clients in Global Market
Table 111. Tumor Necrosis Factor (TNF) Inhibitor Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tumor Necrosis Factor (TNF) Inhibitor Drugs Segment by Type
Figure 2. Tumor Necrosis Factor (TNF) Inhibitor Drugs Segment by Application
Figure 3. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales in Global Market: 2017-2028 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue in 2021
Figure 9. By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
Figure 19. US Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
Figure 24. Germany Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
Figure 33. China Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Tumor Necrosis Factor (TNF) Inhibitor Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Tumor Necrosis Factor (TNF) Inhibitor Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Tumor Necrosis Factor (TNF) Inhibitor Drugs Production Capacity (MT), 2017-2028
Figure 49. The Percentage of Production Tumor Necrosis Factor (TNF) Inhibitor Drugs by Region, 2021 VS 2028
Figure 50. Tumor Necrosis Factor (TNF) Inhibitor Drugs Industry Value Chain
Figure 51. Marketing Channels
